WHO recommends lifesaving tocilizumab, sarilumab for critically ill Covid-19 patients | World NewsBy Mike HarrisonJuly 7, 20210 The WHO urged drug manufacturers to reduce prices of the IL-6 blocking drugs – tocilizumab and sarilumab – and make…
